![]() |
인쇄하기
취소
|
When it comes to the Ministry of Food and Drug Safety’s antismoking supplement, Champix (varenicline), distribution of safety letters has been controversy.
The safety letters were sent to notice of its alcohol interaction and seizure, along with its postponement decision on lowering intensity of caution phrases towards the Champix’s neurologic and psychological risk degree, such as suicidal im...